NCT06677775 Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy Status RECRUITING Phase N/A
NCT06673329 Brodalumab in the Treatment of Immune-Related Adverse Events Status RECRUITING Phase PHASE1
NCT06672926 NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway Status RECRUITING Phase N/A
NCT06671782 A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy Status ACTIVE_NOT_RECRUITING Phase NA
NCT06666270 Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06663007 RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure Status RECRUITING Phase PHASE1/PHASE2
NCT06662708 Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer Status NOT_YET_RECRUITING Phase NA
NCT06661902 Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial Status COMPLETED Phase PHASE1/PHASE2
NCT06660862 Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Status NOT_YET_RECRUITING Phase PHASE4
NCT06652607 PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer Status RECRUITING Phase N/A
NCT06651359 Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors Status RECRUITING Phase NA
NCT06643494 Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical Status SUSPENDED Phase PHASE1/PHASE2
NCT06638541 Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions Status RECRUITING Phase NA
NCT06637943 Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy Status NOT_YET_RECRUITING Phase N/A
NCT06637267 Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau Status RECRUITING Phase N/A
NCT06636682 FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer Status RECRUITING Phase PHASE2
NCT06636526 The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). Status RECRUITING Phase N/A